Hong Kong, China vs Tajikistan: New or unknown treatment history cases: Pulmonary, bacteriologically
Hong Kong, China
2,090
in 2023
Tajikistan
1,824
in 2023
Hong Kong, China rank
92nd
Tajikistan rank
95th
New or unknown treatment history cases: Pulmonary, bacteriologically over time
- Hong Kong, China
- Tajikistan
How they compare
Hong Kong, China currently reports 2,090 against 1,824 in Tajikistan, a difference of 266.
That makes Hong Kong, China's figure about 1.1 times Tajikistan's.
The two have swapped places 2 times across 11 shared years of data; in 2013 it was Hong Kong, China ahead.
Hong Kong, China ranks 92nd and Tajikistan ranks 95th of 197 countries.
Across the 2 decades both report, Hong Kong, China averaged higher in 1 and Tajikistan in 1.
Head to head by decade
| Decade | Hong Kong, China | Tajikistan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2,336 | 2,431 | 94.71 | Tajikistan |
| 2020s | 2,150 | 1,786 | 363 | Hong Kong, China |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new or unknown treatment history cases: pulmonary, bacteriologically, Hong Kong, China or Tajikistan?
- Hong Kong, China, at 2,090 against 1,824 in Tajikistan as of 2023.
- What is the difference in new or unknown treatment history cases: pulmonary, bacteriologically between Hong Kong, China and Tajikistan?
- 266, with Hong Kong, China ahead.
- How many years of comparable data are there for Hong Kong, China and Tajikistan?
- 11 years are reported by both, from 2013 to 2023.
- How do Hong Kong, China and Tajikistan rank globally for new or unknown treatment history cases: pulmonary, bacteriologically?
- Hong Kong, China ranks 92nd and Tajikistan ranks 95th of 197 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New or unknown treatment history cases: Pulmonary, bacteriologically confirmed. Statizoid refreshes it automatically from the source and publishes the full history for both places.